Scientists

Scientists

For science to make the news in a rigorous and attractive way, good sources are needed. Because access to scientific knowledge is a citizen's right.

¿Qué me ofrece?

Help science make headlines with rigour and context. We’ll ask you for feedback on current events in your field and you can participate in the briefings we’ll organise. Need to prepare for an interview? Use our resources on science communication.

Icono
Cómo trabajamos

We’re on the lookout for controversial information about science and we will contact you for your analysis in your area. Do you want to be part of our sources? Contact us. We will not pass your contact details on to anyone else. You can find out more about how we work here.   

Título qué me ofrece
What we offer you
Título cómo trabajamos
How we work

Reactions: New fossils from eukaryotes found in millions-of-years-old rocks

An international team has discovered a new type of molecular fossil in sedimentary rocks from the mid-Proterozoic - which spans from 2.5 billion to 542 million years ago. Protosteroids, a type of lipids found in abundance in those rocks, indicate that eukaryotes were a dominant life form in aquatic environments between 1.6 billion and 800 million years ago, the authors explain in Nature. The finding would confirm the theory of Nobel laureate Konrad Bloch, who predicted the existence of these primordial molecules. 

0

Reactions: Study pushes possibility of ice-free Arctic Septembers to 2030

A model-based study estimates that there will be ice-free Arctic Septembers about a decade earlier than previously predicted. The possibility of this happening between 2030 and 2050 exists even in low-emissions scenarios, which is a more pessimistic estimate than the last IPCC report. The results are published in the journal Nature Communications.

0

Reaction: 'skin-to-skin' with preemies can reduce mortality risk by almost a third

A systematic review published in BMJ Global Health that includes an analysis of 31 studies concludes that the method known as 'skin-to-skin' - or 'kangaroo care' - used with premature or low-weight babies can reduce the risk of mortality by 32% and the risk of serious infections by 15%. The research, funded by the World Health Organisation, shows that starting the technique within 24 hours of birth and carrying it out for at least eight hours a day increases its effectiveness.

0

Reaction: 19 TB positives detected at Ourense high school

The Regional Ministry of Health of the Xunta of Galicia reported a few days ago that it had detected a case of tuberculosis in a high school in Ourense. Yesterday it confirmed that it is following up the contacts of the case after 19 positive tuberculin tests were detected, which implies contact with the bacteria but not necessarily the development of the disease.

0

Reactions to a quantitative study of murders of women environmentalists around the world

A study based on data from the Environmental Justice Atlas says that 81 women were murdered worldwide for their environmental activism: one of them in Spain, 7 in Colombia, 5 in Honduras and 4 in Peru, among other countries. The study, published in Nature Sustainability, says that violence against women defenders is concentrated in conflicts around mining, agribusiness and industrial projects in the Global South. The first author of the study is Dalena Tran, a researcher at the Institute of Environmental Science and Technology of the Autonomous University of Barcelona. 

0

Reaction: genomic sequencing of hundreds of primates reveals clues to identify disease-causing mutations such as cancer

A special issue published in the journals Science and Science Advances shares for the first time the genomes of hundreds of primates, representing 86% of known genera. One of the papers -co-led by the Institute of Evolutionary Biology and the Pompeu Fabra University- analyzes the relationship between the genes of these animals and the risk of suffering from certain diseases such as cancer in humans.

0

Reactions to clinical trial of Parkinson's drug to slow down ALS

A research team in Japan has published a small clinical trial in 20 people with amyotrophic lateral sclerosis (ALS) of a drug called ropinirole, which is commonly used in patients with Parkinson's disease. The authors, whose study is published in Cell Stem Cell, say the treatment is safe and slowed the progression of ALS - an incurable neurodegenerative disease - by an average of 27.9 weeks.

0

Reactions: New particles designed from bacteria-infecting viruses to improve gene therapy

A team of scientists led by the Catholic University of America in Washington has designed new artificial vectors based on viruses to improve gene therapy processes. The main novelty is that they are constructed from viruses that infect bacteria. Among other advantages, this would make it possible to avoid the possible memory of our defences against them and have a greater capacity. According to the authors, who publish their results in the journal Nature Communications, these nanoparticles "have the potential to transform gene therapies and personalised medicine".

0

Reactions: pre-publication claims part of dementia cases are caused by herpes-like viruses

An international team of scientists, led by Stanford University (United States), has designed a study to analyse the relationship between herpes zoster virus infections and the development of dementia. To do so, they took advantage of the introduction of the Zostavax vaccine against this virus in 2013 in Wales (UK), which people over the age of 80 could not receive. After reviewing data from people around this age over the following seven years, they concluded that the vaccine reduced the relative risk of dementia by 20%. According to the authors, their study, which is in prepublication form and has not been peer-reviewed, "leads to the conclusion that shingles vaccination is most likely an effective way to prevent or delay the onset of dementia".

0

Bisphenol A: why has EFSA lowered the tolerable daily intake, and what are the health risks?

A few weeks ago, the European Food Safety Authority (EFSA) said that exposure to bisphenol A through food is a risk to human health. The agency recommended a much lower tolerable daily intake dose than it had its own previous recommendations. In this explainer, we review key facts and documents to cover this issue--which will continue to make the headlines in months and years to come.  

0